Arctigenin attenuates platelet activation and clot retraction by regulation of thromboxane A2 synthesis and cAMP pathway
Pathophysiological reaction of platelets in the blood vessel is an indispensable part of thrombosis and cardiovascular disease, which is the most common cause of death in the world. In this study, we performed in vitro assays to evaluate antiplatelet activity of arctigenin in human platelets and att...
Main Authors: | Gi Suk Nam, Kyung-Soo Nam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332220307289 |
Similar Items
-
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
by: Kyu-Shik Lee, et al.
Published: (2020-04-01) -
Toxicity Study of 28-Day Subcutaneous Injection of Arctigenin in Beagle Dogs
by: Jie Li, et al.
Published: (2019-10-01) -
Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation
by: Heng Li, et al.
Published: (2021-11-01) -
Biodistribution of arctigenin-loaded nanoparticles designed for multimodal imaging
by: Qingxin Cui, et al.
Published: (2017-04-01) -
Arctigenin Attenuates Ischemia/Reperfusion Induced Ventricular Arrhythmias by Decreasing Oxidative Stress in Rats
by: Jing Yang, et al.
Published: (2018-08-01)